| 0 |
VENOUS OCCLUSION |
8 |
| 1 |
DRUG INEFFECTIVE |
6 |
| 2 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
6 |
| 3 |
MEDICATION ERROR |
6 |
| 4 |
WRONG PRODUCT ADMINISTERED |
6 |
| 5 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
5 |
| 6 |
DRUG ADMINISTRATION ERROR |
4 |
| 7 |
EPISTAXIS |
4 |
| 8 |
PYREXIA |
4 |
| 9 |
THROMBOSIS |
4 |
| 10 |
CARDIO-RESPIRATORY ARREST |
3 |
| 11 |
COUGH |
3 |
| 12 |
DECREASED APPETITE |
3 |
| 13 |
HEADACHE |
3 |
| 14 |
HYPERTENSION |
3 |
| 15 |
HYPOTENSION |
3 |
| 16 |
NO ADVERSE EVENT |
3 |
| 17 |
PARAESTHESIA |
3 |
| 18 |
PLEURAL EFFUSION |
3 |
| 19 |
PRODUCT PACKAGING ISSUE |
3 |
| 20 |
PULMONARY EMBOLISM |
3 |
| 21 |
SEIZURE |
3 |
| 22 |
TREMOR |
3 |
| 23 |
UNRESPONSIVE TO STIMULI |
3 |
| 24 |
VOMITING |
3 |
| 25 |
WRONG DRUG ADMINISTERED |
3 |
| 26 |
ABDOMINAL DISTENSION |
2 |
| 27 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
2 |
| 28 |
ANAL INCONTINENCE |
2 |
| 29 |
ARTERIAL STENOSIS |
2 |
| 30 |
ASPERGILLUS TEST POSITIVE |
2 |
| 31 |
BACTERAEMIA |
2 |
| 32 |
BLOOD GLUCOSE INCREASED |
2 |
| 33 |
BRAIN OEDEMA |
2 |
| 34 |
C-REACTIVE PROTEIN INCREASED |
2 |
| 35 |
CENTRAL NERVOUS SYSTEM LESION |
2 |
| 36 |
CEREBRAL ATROPHY |
2 |
| 37 |
CEREBRAL VENTRICLE DILATATION |
2 |
| 38 |
CEREBROVASCULAR ACCIDENT |
2 |
| 39 |
CHROMATURIA |
2 |
| 40 |
CONFUSIONAL STATE |
2 |
| 41 |
CRANIAL NERVE DISORDER |
2 |
| 42 |
CUSHINGOID |
2 |
| 43 |
DYSPNOEA |
2 |
| 44 |
ELECTROENCEPHALOGRAM ABNORMAL |
2 |
| 45 |
ENCEPHALOPATHY |
2 |
| 46 |
FACIAL PARALYSIS |
2 |
| 47 |
FEBRILE NEUTROPENIA |
2 |
| 48 |
HAEMATURIA |
2 |
| 49 |
HEPATOSPLENOMEGALY |
2 |
| 50 |
HYPERGLYCAEMIA |
2 |
| 51 |
HYPERLEUKOCYTOSIS |
2 |
| 52 |
HYPERPHOSPHATAEMIA |
2 |
| 53 |
HYPOKALAEMIA |
2 |
| 54 |
INJECTION SITE EXTRAVASATION |
2 |
| 55 |
INTRACARDIAC THROMBUS |
2 |
| 56 |
KIDNEY ENLARGEMENT |
2 |
| 57 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
2 |
| 58 |
LUNG CONSOLIDATION |
2 |
| 59 |
LYMPHADENOPATHY |
2 |
| 60 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
| 61 |
MENTAL DISORDER |
2 |
| 62 |
MITRAL VALVE DISEASE |
2 |
| 63 |
NEUROPATHY PERIPHERAL |
2 |
| 64 |
OFF LABEL USE |
2 |
| 65 |
PANCYTOPENIA |
2 |
| 66 |
PHARYNGEAL PARAESTHESIA |
2 |
| 67 |
PHYSICAL PRODUCT LABEL ISSUE |
2 |
| 68 |
PNEUMONIA FUNGAL |
2 |
| 69 |
POST PROCEDURAL COMPLICATION |
2 |
| 70 |
PRODUCT DISPENSING ERROR |
2 |
| 71 |
PRODUCT LABEL CONFUSION |
2 |
| 72 |
PRODUCT NAME CONFUSION |
2 |
| 73 |
PRODUCT QUALITY ISSUE |
2 |
| 74 |
SKIN HYPERPIGMENTATION |
2 |
| 75 |
SLOW RESPONSE TO STIMULI |
2 |
| 76 |
THERAPY NON-RESPONDER |
2 |
| 77 |
THROMBOSIS IN DEVICE |
2 |
| 78 |
TUMOUR LYSIS SYNDROME |
2 |
| 79 |
URINARY INCONTINENCE |
2 |
| 80 |
VASCULAR PSEUDOANEURYSM |
2 |
| 81 |
ABDOMINAL INFECTION |
1 |
| 82 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
| 83 |
ACUTE MYELOID LEUKAEMIA |
1 |
| 84 |
ACUTE MYOCARDIAL INFARCTION |
1 |
| 85 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
| 86 |
ACUTE RESPIRATORY FAILURE |
1 |
| 87 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
| 88 |
AMMONIA DECREASED |
1 |
| 89 |
ANAEMIA |
1 |
| 90 |
ANGIOEDEMA |
1 |
| 91 |
ANION GAP INCREASED |
1 |
| 92 |
ANTIPHOSPHOLIPID ANTIBODIES POSITIVE |
1 |
| 93 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
| 94 |
BLAST CELL COUNT INCREASED |
1 |
| 95 |
BLOOD ALBUMIN DECREASED |
1 |
| 96 |
BLOOD CALCIUM DECREASED |
1 |
| 97 |
BLOOD CHLORIDE INCREASED |
1 |
| 98 |
BLOOD CHOLESTEROL INCREASED |
1 |
| 99 |
BLOOD CREATININE DECREASED |
1 |
| 100 |
BLOOD FIBRINOGEN DECREASED |
1 |
| 101 |
BLOOD FIBRINOGEN INCREASED |
1 |
| 102 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
| 103 |
BLOOD MAGNESIUM INCREASED |
1 |
| 104 |
BLOOD PHOSPHORUS DECREASED |
1 |
| 105 |
BLOOD POTASSIUM DECREASED |
1 |
| 106 |
BLOOD PRESSURE DECREASED |
1 |
| 107 |
BLOOD SODIUM DECREASED |
1 |
| 108 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
| 109 |
BLOOD UREA DECREASED |
1 |
| 110 |
BRAIN DEATH |
1 |
| 111 |
BRAIN HERNIATION |
1 |
| 112 |
BRAIN INJURY |
1 |
| 113 |
BURKHOLDERIA TEST POSITIVE |
1 |
| 114 |
CAPILLARY DISORDER |
1 |
| 115 |
CARBON DIOXIDE DECREASED |
1 |
| 116 |
CARDIAC ARREST |
1 |
| 117 |
CARDIAC DISORDER |
1 |
| 118 |
CARDIAC FAILURE CONGESTIVE |
1 |
| 119 |
CARDIAC VENTRICULAR THROMBOSIS |
1 |
| 120 |
CEREBRAL ARTERY EMBOLISM |
1 |
| 121 |
CEREBRAL ISCHAEMIA |
1 |
| 122 |
CEREBRAL VASCULAR OCCLUSION |
1 |
| 123 |
COAGULATION TEST ABNORMAL |
1 |
| 124 |
COAGULOPATHY |
1 |
| 125 |
CONDITION AGGRAVATED |
1 |
| 126 |
CONVULSION |
1 |
| 127 |
COVID-19 |
1 |
| 128 |
CYTOKINE RELEASE SYNDROME |
1 |
| 129 |
CYTOKINE STORM |
1 |
| 130 |
DEATH |
1 |
| 131 |
DEEP VEIN THROMBOSIS |
1 |
| 132 |
DEVICE DIFFICULT TO USE |
1 |
| 133 |
DEVICE ISSUE |
1 |
| 134 |
DISEASE PROGRESSION |
1 |
| 135 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
| 136 |
DRUG DISPENSING ERROR |
1 |
| 137 |
DRUG EFFECT VARIABLE |
1 |
| 138 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
| 139 |
EJECTION FRACTION DECREASED |
1 |
| 140 |
EMBOLISM |
1 |
| 141 |
ENDOTRACHEAL INTUBATION |
1 |
| 142 |
FACTOR V DEFICIENCY |
1 |
| 143 |
FEELING HOT |
1 |
| 144 |
FIBRIN DEGRADATION PRODUCTS INCREASED |
1 |
| 145 |
FLUSHING |
1 |
| 146 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
| 147 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
| 148 |
GRAFT VERSUS HOST DISEASE |
1 |
| 149 |
HAEMATEMESIS |
1 |
| 150 |
HAEMATOCRIT DECREASED |
1 |
| 151 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
1 |
| 152 |
HAEMORRHAGE |
1 |
| 153 |
HYDROCELE |
1 |
| 154 |
HYPOAESTHESIA |
1 |
| 155 |
HYPOXIA |
1 |
| 156 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
1 |
| 157 |
IATROGENIC INJURY |
1 |
| 158 |
INCORRECT PRODUCT FORMULATION ADMINISTERED |
1 |
| 159 |
INJECTION SITE PAIN |
1 |
| 160 |
INJURY ASSOCIATED WITH DEVICE |
1 |
| 161 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
| 162 |
ISCHAEMIC STROKE |
1 |
| 163 |
LETHARGY |
1 |
| 164 |
LEUKOCYTOSIS |
1 |
| 165 |
LOCALISED OEDEMA |
1 |
| 166 |
LYMPHOCYTE COUNT DECREASED |
1 |
| 167 |
MALAISE |
1 |
| 168 |
MONOCYTE COUNT INCREASED |
1 |
| 169 |
MUCOSAL INFLAMMATION |
1 |
| 170 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
| 171 |
NAUSEA |
1 |
| 172 |
NEOPLASM PROGRESSION |
1 |
| 173 |
NEUTROPHIL COUNT DECREASED |
1 |
| 174 |
OEDEMA |
1 |
| 175 |
OPERATIVE HAEMORRHAGE |
1 |
| 176 |
OUT OF SPECIFICATION TEST RESULTS |
1 |
| 177 |
PAIN |
1 |
| 178 |
PALLOR |
1 |
| 179 |
PANCREATITIS |
1 |
| 180 |
PARAESTHESIA ORAL |
1 |
| 181 |
PH BODY FLUID ABNORMAL |
1 |
| 182 |
PLATELET COUNT DECREASED |
1 |
| 183 |
PNEUMATOSIS |
1 |
| 184 |
PNEUMATOSIS INTESTINALIS |
1 |
| 185 |
PNEUMONIA |
1 |
| 186 |
PNEUMORETROPERITONEUM |
1 |
| 187 |
POST PROCEDURAL STROKE |
1 |
| 188 |
PRESYNCOPE |
1 |
| 189 |
PROCALCITONIN INCREASED |
1 |
| 190 |
PRODUCT CONTAINER ISSUE |
1 |
| 191 |
PRODUCT DESIGN ISSUE |
1 |
| 192 |
PRODUCT LABEL ISSUE |
1 |
| 193 |
PRODUCT PACKAGE ASSOCIATED INJURY |
1 |
| 194 |
PRODUCT PACKAGING CONFUSION |
1 |
| 195 |
PRODUCT RECONSTITUTION ISSUE |
1 |
| 196 |
PROTEIN TOTAL DECREASED |
1 |
| 197 |
PROTHROMBIN TIME PROLONGED |
1 |
| 198 |
PULSE ABSENT |
1 |
| 199 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
| 200 |
RASH |
1 |
| 201 |
RED BLOOD CELL COUNT DECREASED |
1 |
| 202 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
| 203 |
RENAL FAILURE |
1 |
| 204 |
RESPIRATORY RATE DECREASED |
1 |
| 205 |
RETICULOCYTE COUNT DECREASED |
1 |
| 206 |
RETINAL ARTERY OCCLUSION |
1 |
| 207 |
RIGHT-TO-LEFT CARDIAC SHUNT |
1 |
| 208 |
SERUM FERRITIN INCREASED |
1 |
| 209 |
SINUS DISORDER |
1 |
| 210 |
SPINAL OSTEOARTHRITIS |
1 |
| 211 |
SYNCOPE |
1 |
| 212 |
TACHYCARDIA |
1 |
| 213 |
TACHYPNOEA |
1 |
| 214 |
THROMBOCYTOPENIA |
1 |
| 215 |
TONSILLECTOMY |
1 |
| 216 |
TRANSCRIPTION MEDICATION ERROR |
1 |
| 217 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
| 218 |
URINARY TRACT INFECTION |
1 |
| 219 |
VENOUS HAEMORRHAGE |
1 |
| 220 |
VENTRICULAR FIBRILLATION |
1 |
| 221 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
| 222 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |